Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Antithrombin III  [Clear All Filters]
2015
Tin A, Grams ME, Maruthur NM, et al. "Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study." Clin J Am Soc Nephrol. 2015;10(5):784-90.
2012
Alonso A, Tang W, Agarwal SK, Soliman EZ, Chamberlain AM, Folsom AR. "Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study." Int J Cardiol. 2012;155(2):217-22.
1997
Nieto FJ, Sorlie P, Comstock GW, et al. "Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link?" Arterioscler Thromb Vasc Biol. 1997;17(9):1780-5.
1994
Conlan MG, Folsom AR, Finch A, et al. "Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Thromb Haemost. 1994;72(4):551-6.
1992
Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R. "Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 1992;2(4):471-80.
Folsom AR, Conlan MG, Davis CE, Wu KK. "Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators." Ann Epidemiol. 1992;2(4):481-94.
Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen YL. "Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study." Ann Epidemiol. 1992;2(5):723-33.